← Leaderboards
Raphael J Landovitz
University Of California Los Angeles
$12,045,588
Attributed
$22,818,970
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,573,780 · 6
By mechanism
UM1$21,546,764 · 1
P30$2,211,500 · 2
K23$789,985 · 1
M01$25,531 · 2
Top collaborators
- Judith S. Currier5 shared
- Corrina Moucheraud1 shared
- Steven Shoptaw1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Judith S. Currier$525,401,794
- Steven Shoptaw$45,062,464
- Pamina Mae Gorbach$27,489,571
- Cathy J Reback$13,169,841
- Margaret L. Stuber$2,107,650
Others in their field
Top investigators on “Aids Prevention”
- Judith S. Currier · University Of California Los Angeles$494,857,170
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$398,787,960
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$310,253,675
- Lawrence Corey · Fred Hutchinson Cancer Center$298,388,501
- Constance Ann Benson · University Of California, San Diego$291,928,206
- Daniel R Kuritzkes · Brigham And Women'S Hospital$281,830,629
Research focus
Aids PreventionMentorsComorbidityPrevention StrategyHiv InfectionsDesignCaliforniaCommunitiesPreventionLos AngelesEnrollmentResearch PersonnelInfectionSuccessMultidisciplinaryMental HealthNovel StrategiesCollaborationsEpidemicAcquired Immunodeficiency SyndromePersonsMen Who Have Sex With MenMentorshipArea
Grant awards (15)
UCLA AIDS Prevention and Treatment Clinical Trials Unit$3,585,709
UM1 · FY2025 · AI · contact PI
Center for HIV Identification, Prevention and Treatment Services$1,499,315
P30 · FY2025 · MH · contact PI
Administrative Core$456,690
P30 · FY2025 · MH · contact PI
UCLA AIDS Prevention and Treatment Clinical Trials Unit$3,954,316
UM1 · FY2024 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit$3,794,297
UM1 · FY2023 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit$4,384,228
UM1 · FY2022 · AI
Financially incentivizing HIV prevention among high-incidence populations in LA County: Preparing for implementation$255,495
P30 · FY2022 · MH
UCLA AIDS Prevention and Treatment Clinical Trials Unit$5,828,214
UM1 · FY2021 · AI
Biomedical Prevention for HIV in High-risk Populations with Comorbidities$157,397
K23 · FY2013 · DA · contact PI
Biomedical Prevention for HIV in High-risk Populations with Comorbidities$157,397
K23 · FY2012 · DA · contact PI
Biomedical Prevention for HIV in High-risk Populations with Comorbidities$157,397
K23 · FY2011 · DA · contact PI
Biomedical Prevention for HIV in High-risk Populations with Comorbidities$157,397
K23 · FY2010 · DA · contact PI
THE OPTIMIZED TREATMENT THAT INCLUDES OR OMITS NRTIS (OPTIONS) TRIAL: A RANDOMIZ$7,911
M01 · FY2010 · RR · contact PI
Biomedical Prevention for HIV in High-risk Populations with Comorbidities$160,397
K23 · FY2009 · DA · contact PI
THE OPTIMIZED TREATMENT THAT INCLUDES OR OMITS NRTIS (OPTIONS) TRIAL: HIV$17,620
M01 · FY2009 · RR · contact PI